Polyvinyl Alcohol Embolization Microspheres

Status Enrolling by invitation

Clinical Trial Summary

To evaluate the safety and efficacy of polyvinyl alcohol embolization microspheres developed and manufactured by Shanghai Huihe Medical Technology Co., LTD. (hereinafter referred to as Huihe Medical) for transarterial chemoembolization of primary liver cancer using a prospective, multi-center, randomized controlled method

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05770635
Study type	Interventional
Source	Shanghai Huihe Medical Technology Co., Ltd
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	December 28, 2022
Completion date	December 28, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03161925` - Chinese Liver Cancer Clinical Survey	N/A
Completed	`NCT00261378` - Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation	Phase 2
Enrolling by invitation	`NCT05609448` - MRI-guided Holmium-166 Radioembolization	N/A
Recruiting	`NCT05714124` - Liver Embolization Approaches for Tumor Management
Not yet recruiting	`NCT05353894` - Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers	Phase 1
Completed	`NCT03518632` - Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE)	N/A
Terminated	`NCT00003530` - Antineoplaston Therapy in Treating Patients With Primary Liver Cancer	Phase 2
Recruiting	`NCT04806464` - Clinical Study of VG161 in Subjects With Advanced Primary Liver Cancer	Phase 1
Recruiting	`NCT06342414` - An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Completed	`NCT01116804` - Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)	Phase 1
Recruiting	`NCT03067493` - RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial	Phase 2
Completed	`NCT05183776` - Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT	N/A
Not yet recruiting	`NCT06430983` - Recurrent Liver Cancer: Reconceptualization and Reevaluation
Recruiting	`NCT05677724` - Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment
Not yet recruiting	`NCT03178929` - Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma	N/A
Recruiting	`NCT05267080` - Registry on Percutaneous Electrochemotherapy
Not yet recruiting	`NCT02327819` - The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer	N/A
Completed	`NCT01640522` - Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms	N/A
Completed	`NCT00408122` - Evaluation of Preoperative Investigations in Patients With Liver Cancer	N/A
Recruiting	`NCT03297255` - Primary Liver Cancer Cohort of South China	N/A